Direct-acting antiviral agents do not increase the incidence of hepatocellular carcinoma development: a prospective, multicenter study.
Tatsuya IdeHironori KogaMasahito NakanoSatoru HashimotoHiroshi YatsuhashiNobito HiguchiMakoto NakamutaSatoshi OedaYuichiro EguchiSatoshi ShakadoShotaro SakisakaYoko YoshimaruYutaka SasakiYuichi HonmaMasaru HaradaMasataka SeikeTatsuji MaeshiroSatoshi MiumaKazuhiko NakaoSeiichi MawatariAkio IdoKenji NagataShuichi MatsumotoYuko TakamiTetsuo SohdaTatsuyuki KakumaTakuji TorimuraPublished in: Hepatology international (2019)
Although the results of our prospective study suggested that achieving SVR by DAA treatment reduces the incidence of HCC, HCC development still occurs. Careful follow-up is important in patients with risk factors.
Keyphrases